Blue Owl Capital Holdings LP
Reported holdings as of Q2 2026, from 19 quarterly filings.
Holdings
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP | SPCX | $239.0M | 1,398,815 | - | new | NEW | |
| AKTIS ONCOLOGY INC | AKTS | $99.0M | 3,070,219 | -0.31pp | 2q | -2.9%-$2.9M | |
| CULLINAN THERAPEUTICS INC | CGEM | $28.0M | 1,539,764 | -3.07pp | 11q | -19.4%-$6.7M | |
| LARIMAR THERAPEUTICS INC | LRMR | $27.9M | 9,163,157 | -4.40pp | 11q | +28.7%+$6.2M | |
| NUVEEN CHURCHILL DIRECT LEND | NCDL | $26.6M | 2,143,626 | -3.32pp | 8q | HELD | |
| MAPLIGHT THERAPEUTICS INC | MPLT | $26.2M | 729,929 | -1.56pp | 3q | -27.4%-$9.9M | |
| CAPITAL ONE FINL CORP | COF | $24.0M | 119,757 | - | new | NEW | |
| BLUE OWL CAPITAL CORPORATION | OBDC | $22.2M | 2,045,070 | -2.73pp | 15q | HELD | |
| DEEP FISSION INC | FISN | $14.7M | 1,333,333 | - | new | NEW | |
| DELL TECHNOLOGIES INC | DELL | $14.2M | 32,961 | +1.53pp | 5q | +137.1%+$8.2M | |
| HOLLEY INC | HLLY | $11.2M | 4,376,888 | -1.82pp | 8q | +3.3%+$357.0K | |
| EYEPOINT INC | EYPT | $10.9M | 762,594 | -1.52pp | 7q | -16.4%-$2.1M | |
| SAGIMET BIOSCIENCES INC | SGMT | $9.7M | 1,260,544 | +1.00pp | 11q | +277.5%+$7.2M | |
| CORVUS PHARMACEUTICALS INC | CRVS | $9.1M | 608,600 | -0.77pp | 2q | +11.7%+$950.2K | |
| ARTIVA BIOTHERAPEUTICS INC | ARTV | $8.5M | 874,542 | - | new | NEW | |
| COMPASS THERAPEUTICS INC | CMPX | $7.9M | 3,624,076 | -2.99pp | 11q | +23.2%+$1.5M | |
| CONDUENT INC | CNDT | $7.4M | 5,036,595 | -0.63pp | 8q | HELD | |
| RHYTHM PHARMACEUTICALS INC | RYTM | $6.8M | 61,455 | -0.41pp | 2q | HELD | |
| COMPASS PATHWAYS PLC | CMPS | $6.4M | 450,000 | - | new | NEW | |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | $6.1M | 182,638 | -0.79pp | 11q | -39.7%-$4.0M | |
| PALVELLA THERAPEUTICS INC NE | PVLA | $5.5M | 36,259 | -0.21pp | 7q | +16.0%+$764.1K | |
| IMAGENEBIO INC | IMA | $5.4M | 917,692 | -0.47pp | 4q | -4.3%-$245.7K | |
| COMPASS PATHWAYS PLC OPT | CMPS | $5.2M | options only | -0.60pp | 2q | OPTIONS | |
| VIRIDIAN THERAPEUTICS INC | VRDN | $4.8M | 260,000 | - | new | NEW | |
| IMMIX BIOPHARMA INC | IMMX | $4.5M | 437,552 | -0.66pp | 3q | -20.1%-$1.1M | |
| ORIC PHARMACEUTICALS INC | ORIC | $4.3M | 400,000 | +0.14pp | 3q | +166.7%+$2.7M | |
| LENZ THERAPEUTICS INC | LENZ | $4.3M | 756,722 | -0.60pp | 3q | +49.3%+$1.4M | |
| AQUESTIVE THERAPEUTICS INC | AQST | $3.9M | 942,932 | -0.91pp | 10q | -30.0%-$1.7M | |
| STARWOOD PPTY TR INC | STWD | $3.2M | 196,355 | -0.25pp | 2q | +23.8%+$619.3K | |
| EVOMMUNE INC | EVMN | $2.4M | 180,000 | -0.26pp | 2q | +80.0%+$1.1M | |
| ELEDON PHARMACEUTICALS INC | ELDN | $2.2M | 566,509 | -0.84pp | 7q | -60.1%-$3.4M | |
| CABALETTA BIO INC | CABA | $2.2M | 714,710 | - | new | NEW | |
| CHIME FINL INC | CHYM | $1.8M | 89,878 | - | new | NEW | |
| CONTEXT THERAPEUTICS INC | CNTX | $1.6M | 2,934,015 | -3.34pp | 9q | -42.3%-$1.2M | |
| WW INTL INC | WW | $1.3M | 84,399 | -0.15pp | 2q | -11.7%-$179.5K | |
| MARKER THERAPEUTICS INC | MRKR | $814.7K | 554,250 | -0.07pp | 7q | HELD | |
| ERASCA INC OPT | ERAS | $795.0K | options only | - | new | OPTIONS | |
| ADC THERAPEUTICS SA | ADCT | $784.9K | 733,568 | -0.58pp | 16q | HELD | |
| CYBIN INC | HELP | $396.0K | 59,911 | - | new | NEW | |
| FOLD HLDGS INC | FLD | $385.5K | 856,632 | -0.25pp | 5q | HELD | |
| NIOCORP DEVS LTD | NIOBW | $381.0K | 268,280 | -0.08pp | 8q | -16.2%-$73.6K | |
| ELEDON PHARMACEUTICALS INC OPT | ELDN | $285.0K | options only | - | new | OPTIONS | |
| REZOLVE AI PLC | RZLVW | $214.0K | 235,121 | -0.02pp | 8q | HELD | |
| BRAND ENGAGEMENT NETWORK INC | BNAIW | $203.5K | 1,453,808 | -0.08pp | 8q | -12.8%-$29.8K | |
| PIPER SANDLER COMPANIES | PIPR | $175.6K | 2,428 | -0.02pp | 2q | HELD | |
| ENGENE THERAPEUTICS INC | $148.2K | 511,177 | - | new | NEW | ||
| LARIMAR THERAPEUTICS INC OPT | LRMR | $145.7K | options only | -0.49pp | 2q | OPTIONS | |
| CELCUITY INC | CELC | $130.7K | 1,249 | - | new | NEW | |
| COMPASS THERAPEUTICS INC OPT | CMPX | $106.3K | options only | -0.12pp | 2q | OPTIONS | |
| STABLECOINX INC | $102.5K | 250,000 | - | new | NEW | ||
| ENERGY TRANSFER L P | ET | $101.8K | 5,326 | -0.01pp | 2q | HELD | |
| CARIS LIFE SCIENCES INC | CAI | $84.0K | 4,711 | -0.01pp | 2q | HELD | |
| VODAFONE GROUP PLC | VOD | $71.0K | 5,371 | - | new | NEW | |
| DAVE INC | DAVEW | $68.4K | 28,750 | +0.01pp | 8q | HELD | |
| MURANO GLOBAL INVT PLC | MRNO | $62.9K | 261,875 | - | new | NEW | |
| ALPHA MODUS HLDGS INC | AMODW | $55.6K | 1,854,665 | -0.01pp | 7q | HELD | |
| ROADZEN INC | RDZNW | $42.8K | 225,000 | flat | 8q | HELD | |
| ALPHA MODUS HLDGS INC | $42.0K | 9,853 | - | new | NEW | ||
| AEON BIOPHARMA INC | AEON | $30.5K | 42,353 | -0.01pp | 6q | HELD | |
| SOUTHLAND HLDGS INC | SLNDWS | $25.8K | 860,302 | -0.01pp | 8q | HELD | |
| BLUE GOLD LTD | BGLWW | $21.0K | 175,000 | -0.01pp | 5q | HELD | |
| SHF HOLDINGS INC | SHFS | $18.2K | 75,897 | -0.01pp | 6q | HELD | |
| BLACKSKY TECHNOLOGY INC | BKSYWS | $17.5K | 350,000 | flat | 8q | HELD | |
| TEVOGEN BIO HLDGS INC | TVGNW | $12.0K | 200,000 | flat | 8q | HELD | |
| ZEO ENERGY CORP | ZEOWW | $10.0K | 250,000 | - | new | NEW | |
| LIVEWIRE GROUP INC | LVWRWS | $8.0K | 400,000 | - | new | NEW | |
| NVNI GROUP LIMITED | NVNIW | $6.0K | 200,000 | - | new | NEW | |
| KATAPULT HOLDINGS INC | KPLT | $5.4K | 5,421 | flat | 2q | HELD | |
| CID HOLDCO INC | DAICW | $4.4K | 444,515 | flat | 5q | HELD | |
| BAIRD MED INVT HLDGS LTD | BDMDW | $4.0K | 100,000 | flat | 7q | HELD | |
| PAGAYA TECHNOLOGIES LTD | PGYWW | $2.4K | 48,661 | flat | 8q | HELD | |
| STARDUST PWR INC | SDSTW | $2.2K | 16,666 | flat | 8q | HELD | |
| LIMINATUS PHARMA INC. | LIMNW | $2.0K | 50,000 | flat | 5q | HELD | |
| WALDENCAST PLC | WALDW | $1.7K | 33,333 | flat | 8q | HELD | |
| XBP GLOBAL HOLDINGS INC | XBPEW | $1.5K | 24,778 | flat | 8q | HELD | |
| ASPIRE BIOPHARMA HLDGS INC | ASBPW | $1.0K | 50,000 | flat | 6q | HELD |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $296.4M | 44.6% |
| Funds & ETFs | $48.9M | 7.4% |
| Banks & Lending | $26.3M | 4.0% |
| Computer Hardware | $14.2M | 2.1% |
| Autos & Aerospace | $11.2M | 1.7% |
| Other sectors | $13.5M | 2.0% |
| Not classified | $254.1M | 38.2% |
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $664.5M | 76 | 20 | 11 | 16 | 18 | 78.5% | 42 |
| Q1 2026 | $372.2M | 74 | 20 | 12 | 16 | 24 | 69.3% | 44 |
| Q4 2025 | $324.0M | 78 | 16 | 16 | 13 | 10 | 61.8% | 51 |
| Q3 2025 | $322.1M | 72 | 9 | 7 | 12 | 9 | 61.7% | 43 |
| Q2 2025 | $309.9M | 72 | 13 | 6 | 14 | 14 | 66.1% | 42 |
| Q1 2025 | $310.1M | 73 | 11 | 17 | 4 | 16 | 68.8% | 45 |
| Q4 2024 | $434.0M | 78 | 12 | 10 | 14 | 67 | 71.5% | 45 |
| Q3 2024 | $518.4M | 133 | 95 | 11 | 9 | 3 | 65.1% | 45 |
| Q2 2024 | $359.6M | 41 | 12 | 6 | 7 | 15 | 68.0% | 46 |
| Q1 2024 | $500.6M | 44 | 7 | 15 | 5 | 5 | 69.7% | 45 |
| Q4 2023 | $418.3M | 42 | 30 | 2 | 1 | 3 | 73.3% | 46 |
| Q3 2023 | $129.3M | 15 | 3 | 0 | 2 | 4 | 98.8% | 45 |
| Q2 2023 | $162.3M | 16 | 3 | 2 | 3 | 2 | 96.6% | 42 |
| Q1 2023 | $156.1M | 15 | 2 | 3 | 1 | 30 | 97.4% | 41 |
| Q4 2022 | $235.0M | 43 | 5 | 5 | 0 | 1 | 81.0% | 44 |
| Q3 2022 | $230.9M | 39 | 2 | 6 | 0 | 0 | 80.1% | 45 |
| Q2 2022 | $203.6M | 37 | 6 | 5 | 0 | 0 | 81.0% | 43 |
| Q1 2022 | $227.2M | 31 | 2 | 7 | 0 | 0 | 84.0% | 46 |
| Q4 2021 | $301.2M | 29 | 0 | 0 | 0 | 0 | 89.3% | 136 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.